Outset Medical, Inc.
OM
$0.553
-$0.0005-0.09%
| Weiss Ratings | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.19 | |||
| Price History | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -23.62% | |||
| 30-Day Total Return | -31.90% | |||
| 60-Day Total Return | -50.18% | |||
| 90-Day Total Return | -2.98% | |||
| Year to Date Total Return | -52.74% | |||
| 1-Year Total Return | -74.52% | |||
| 2-Year Total Return | -97.24% | |||
| 3-Year Total Return | -98.57% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -89.40% | |||
| 52-Week Low % Change | 27.24% | |||
| Price | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.22 | |||
| 52-Week Low Price | $0.44 | |||
| 52-Week Low Price (Date) | Sep 12, 2024 | |||
| 52-Week High Price (Date) | May 06, 2024 | |||
| Valuation | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 29.72M | |||
| Enterprise Value | 72.90M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.49 | |||
| Earnings Per Share Growth | -28.80% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.26 | |||
| Price/Book (Q) | 1.09 | |||
| Enterprise Value/Revenue (TTM) | 0.64 | |||
| Price | $0.55 | |||
| Enterprise Value/EBITDA (TTM) | -0.71 | |||
| Enterprise Value/EBIT | -0.68 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 52.74M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 669 231 8200 | |||
| Address | 3052 Orchard Drive San Jose, CA 95134 | |||
| Website | www.outsetmedical.com | |||
| Country | United States | |||
| Year Founded | 2003 | |||
| Profitability | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -94.83% | |||
| Profit Margin | -112.56% | |||
| Management Effectiveness | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -22.86% | |||
| Return on Equity | -- | |||
| Income Statement | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 113.69M | |||
| Total Revenue (TTM) | 113.69M | |||
| Revenue Per Share | $2.16 | |||
| Gross Profit (TTM) | 39.14M | |||
| EBITDA (TTM) | -102.09M | |||
| EBIT (TTM) | -107.82M | |||
| Net Income (TTM) | -127.98M | |||
| Net Income Avl. to Common (TTM) | -127.98M | |||
| Total Revenue Growth (Q YOY) | -3.41% | |||
| Earnings Growth (Q YOY) | 33.58% | |||
| EPS Diluted (TTM) | -2.49 | |||
| EPS Diluted Growth (Q YOY) | 36.71% | |||
| Balance Sheet | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 158.69M | |||
| Cash Per Share (Q) | $3.01 | |||
| Total Current Assets (Q) | 258.22M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 26.82M | |||
| Current Ratio (Q) | 5.690 | |||
| Book Value Per Share (Q) | $0.51 | |||
| Total Assets (Q) | 275.80M | |||
| Total Current Liabilities (Q) | 45.38M | |||
| Total Debt (Q) | 201.86M | |||
| Total Liabilities (Q) | 248.98M | |||
| Total Common Equity (Q) | 26.82M | |||
| Cash Flow | OM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 103.94M | |||
| Cash from Financing (TTM) | 67.87M | |||
| Net Change in Cash (TTM) | 55.51M | |||
| Levered Free Cash Flow (TTM) | -69.93M | |||
| Cash from Operations (TTM) | -116.30M | |||
